NCT04612517View on ClinicalTrials.gov

A Multiple Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 26, 2020

Primary Completion Date

August 30, 2021

Study Completion Date

August 30, 2021

Conditions
Healthy
Interventions
DRUG

ZP7570

Each subject will be randomly allocated to multiple doses of ZP7570 at one of four dose levels in each cohort.

DRUG

Placebo

Placebo; corresponding volume

Trial Locations (1)

41460

Profil Institut für Stoffwechselforschung GmbH, Neuss

Sponsors

Lead Sponsor

Zealand Pharma
All Listed Sponsors
lead

Zealand Pharma

INDUSTRY

NCT04612517 - A Multiple Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570 | Biotech Hunter | Biotech Hunter